Home2022November

Month: November 2022

Sana Biotechnology to lay off 15% of its employees

November 30, 2022 bionetworks Comments Off on Sana Biotechnology to lay off 15% of its employees

The Seattle-based biotech is halting investment in a program aimed at heart failure. Click here to view original post Click here to view original post

Eli Lilly’s Alzheimer’s drug clears more amyloid early than Aduhelm in first-ever head-to-head. Will it matter?

November 30, 2022 mcanady Comments Off on Eli Lilly’s Alzheimer’s drug clears more amyloid early than Aduhelm in first-ever head-to-head. Will it matter?

Ahead of the FDA’s decision on Eli Lilly’s Alzheimer’s drug donanemab in February, the Big Pharma is dropping a first cut of data from one of the more interesting trials — but less important in […]

Ambulance company AMR plans layoffs for 100-plus employees in Pierce County

November 30, 2022 bionetworks Comments Off on Ambulance company AMR plans layoffs for 100-plus employees in Pierce County

The Colorado-based ambulance services company plans to cut 130 staff by Jan. 28, according to a state filing, as it reduces its Pierce County operations. Click here to view original post Click here to view […]

QuidelOrtho to Host Investor Day on December 13, 2022

November 30, 2022 mcanady Comments Off on QuidelOrtho to Host Investor Day on December 13, 2022

SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will host an Investor Day on […]

FDA Approves First Fecal Microbiota Product

November 30, 2022 bionetworks Comments Off on FDA Approves First Fecal Microbiota Product

FDA approves the first fecal microbiota product, Rebyota. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. It is for used after an […]

Rockville’s RegenxBio lays out potential path to market for its first gene therapy treatments

November 30, 2022 bionetworks Comments Off on Rockville’s RegenxBio lays out potential path to market for its first gene therapy treatments

The 13-year-old company has been expanding, but has yet to sell a product of its own. Click here to view original post Click here to view original post

BMS’ Zeposia and AbbVie’s Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn’s Disease Markets, Spherix Reports

November 30, 2022 bionetworks Comments Off on BMS’ Zeposia and AbbVie’s Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn’s Disease Markets, Spherix Reports

Takeda’s Entyvio, Janssen’s Stelara, and AbbVie’s Humira leave the most on the table when first-line biologic or small molecule agents are prescribed in inflammatory bowel disease EXTON, Pa., Nov. 30, 2022 /PRNewswire/ — US gastroenterologists […]

Additional US$ 4 Million Received for Next Development Steps of MedinCell's 6-Month Active Injectable Bioresorbable Subcutaneous Contraceptive

November 30, 2022 bionetworks Comments Off on Additional US$ 4 Million Received for Next Development Steps of MedinCell's 6-Month Active Injectable Bioresorbable Subcutaneous Contraceptive

MONTPELLIER, France–(BUSINESS WIRE)–MedinCell (Paris:MEDCL) has received an additional US$ 4 million payment from the Bill & Melinda Gates Foundation This amount is intended to finance the next steps of MedinCell’s program mdc-WWM in readiness to […]

Merck sues Johns Hopkins for licensing Keytruda patents in secret and in conflict with research collaboration

November 30, 2022 bionetworks Comments Off on Merck sues Johns Hopkins for licensing Keytruda patents in secret and in conflict with research collaboration

Merck filed a lawsuit against Johns Hopkins University in Maryland federal court on Tuesday, arguing that the storied university obtained illegal patents as part of its research collaboration with the company and related to its […]

BIOS Welcomes Serial Entrepreneur Deepak Savadatti as CEO

November 30, 2022 mcanady Comments Off on BIOS Welcomes Serial Entrepreneur Deepak Savadatti as CEO

CARLSBAD, Calif., Nov. 30, 2022 /PRNewswire/ — BIOS, a NASA spinoff and leader in human wellness and horticultural lighting technologies today announced Deepak Savadatti as the company’s new Chief Executive Officer. Savadatti, being an energetic […]

Posts navigation

1 2 … 54 »